Jim Cramer Latest Stocks: 23 Stocks He Just Talked About

14. McKesson Corporation (NYSE:MCK)

Number of Hedge Fund Holders In Q3 2024: 57

McKesson Corporation (NYSE:MCK) is an American pharmacy and healthcare products distributor. Like its peers in the pharmacy and benefits management industry, the tail-end of 2024 has shifted the narrative for the firm. McKesson Corporation (NYSE:MCK)’s stock is down 6.3% over the last month as investors ponder over legislative actions against the benefits management and pharmaceutical industries. The dip follows an already erratic year for McKesson Corporation (NYSE:MCK)’s stock. These include a 12% dip in August when the firm’s pharma revenue of $71.7 billion missed analyst estimates of $74.1 billion. The shares soared by 16% in November after McKesson Corporation (NYSE:MCK) raised full-year profit guidance to $32.40 to $33 per share from an earlier $31.75 and $32.55 per share. Cramer focused on the potential actions against the firm:

“Can we just say that the middlemen have been under fire for decades. And they are always, they always, McKesson is always standing. McKesson has just defied everyone. Right. They defy everybody. No one can touch McKesson.”